Bart van Rhijn
Finanzdirektor/CFO bei NANOBIOTIX
Vermögen: - $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Bart van Rhijn
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
13
| Public Company | Medical Specialties | 13 |
Servier Pharmaceuticals LLC
Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company is based in Boston, MA. Servier Pharmaceuticals continues to build a treatment portfolio with a current focus on oncology within acute lymphoblastic leukemia. The company invests in innovative research and development through development or partnerships to best address the unmet needs of patients. Additionally, the company is proud to offer financial assistance to not only support patients and their families but a variety of focused advocacy groups and healthcare professionals as well. Servier Pharmaceuticals is committed to engaging with patients, caregivers, families, and patient organizations to ensure their voices are heard in every initiative. The company's responsibility is to help make the world a better place for patients and their families, and it strives to have consistent and concise transparency throughout all clinical trials and research and development for the benefit of all patients. The company was founded in 1954. The CEO is David K. Lee.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Galderma International SAS
Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Bart van Rhijn
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Corporate Officer/Principal | |
SANOFI | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
VETOQUINOL SA | Pharmaceuticals: Major | Director/Board Member | |
International Distillers & Vintners Ltd.
International Distillers & Vintners Ltd. Food DistributorsDistribution Services International Distillers & Vintners Ltd. is a British company that imports and distributes specialty beers and spirits worldwide, including the Americas. The joint venture company's mission is to provide nationwide service to their customers while committing to long term brand building activities. The company prides itself on its broad range of high-quality products, including wines, spirits, and beer from countries around the world. The company is the exclusive importer and distributor of a variety of products. | Food Distributors | Corporate Officer/Principal | |
Ecole Nationale des Ponts et Chaussées | College/University | Corporate Officer/Principal | |
University of Maryland | College/University | Undergraduate Degree | |
Providence College & Theological Seminary | College/University | Doctorate Degree | |
MSD Vaccines Ltd.
MSD Vaccines Ltd. Pharmaceuticals: OtherHealth Technology MSD Vaccines Ltd. manufactures and supplies vaccines. Its main way of achieving this goal is to develop and make available innovative vaccines against a wide spectrum of diseases. It also dedicated to increasing the understanding of the value of vaccines and vaccination by providing relevant and accurate information on their quality, safety and efficacy. The company was founded in 1975 and is headquartered in Maidenhead, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member | |
ALAUNOS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Institut Mines-Télécom
Institut Mines-Télécom Miscellaneous Commercial ServicesCommercial Services Institut Mines-Télécom provides information technology education services. It is an organization for higher education and research in the information and communication technologies and sciences. The firm also provides information technology education services. The company was founded in 1844 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
Sciences Po | College/University | Undergraduate Degree | |
ESSEC Business School | College/University | Masters Business Admin | |
École Normale Supérieure | College/University | Doctorate Degree | |
ESCP Europe Campus Paris | College/University | Masters Business Admin | |
Institut Supérieur d'Electronique de Paris | College/University | Director/Board Member | |
SARTORIUS STEDIM BIOTECH | Medical Specialties | Director/Board Member | |
Université Paris II Panthéon Assas | College/University | Graduate Degree | |
University of Parma | College/University | Doctorate Degree | |
Sanofi España SA | Director/Board Member | ||
Sanofi Pasteur MSD SA | Corporate Officer/Principal | ||
Sanofi Pasteur MSD SNC
Sanofi Pasteur MSD SNC Pharmaceuticals: MajorHealth Technology Sanofi Pasteur MSD SNC is engaged in the wholesale of pharmaceutical products. The company was founded on August 16, 1993 and is headquartered in Lyon, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Capgemini Consulting SAS
Capgemini Consulting SAS Miscellaneous Commercial ServicesCommercial Services Capgemini Consulting SAS provides management consulting and outsourcing services. The firm advises and supports organizations in transforming their business. The company was founded on July 12, 2004 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
AXA Partners Holdings Ltd.
AXA Partners Holdings Ltd. Multi-Line InsuranceFinance AXA Partners Holdings Ltd. provides accident, sickness, and unemployment insurance services. The company was founded on September 29, 2003 and is headquartered in London, the United Kingdom. | Multi-Line Insurance | Human Resources Officer | |
Themis Bioscience GmbH
Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
ISOFOL MEDICAL AB | Pharmaceuticals: Major | Director/Board Member | |
Institut Supérieur de Gestion | College/University | Graduate Degree | |
VALNEVA | Biotechnology | Chairman | |
Axa Research Fund | Founder | ||
Shire Pharmaceuticals LLC
Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sanofi Pasteur MSD Ltd. (Ireland)
Sanofi Pasteur MSD Ltd. (Ireland) BiotechnologyHealth Technology Part of Merck & Co., Inc., Sanofi Pasteur MSD Ltd. is a private company based in Dublin, Ireland. The Irish company develops and produces vaccines. | Biotechnology | Director/Board Member | |
Sanofi Pasteur MSD SA (Spain)
Sanofi Pasteur MSD SA (Spain) Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Sanofi Pasteur MSD SA is a private company based in Madrid, Spain. The Spanish company develops vaccines. | Pharmaceuticals: Major | Director/Board Member | |
Smag Consulting SARL | Chief Executive Officer | ||
Roc SA
Roc SA Real Estate DevelopmentFinance Roc SA provides housing development services. | Real Estate Development | Corporate Officer/Principal | |
Medisix Therapeutics, Inc.
Medisix Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Medisix Therapeutics, Inc. develops novel cellular therapies to address T cell malignancies. The company is headquartered in Singapore. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Pharmaengine Europe SARL
Pharmaengine Europe SARL Pharmaceuticals: MajorHealth Technology Part of PharmaEngine, Inc., Pharmaengine Europe SARL develops pharmaceutical products for cancer diseases. The private company is based in Paris, France. The CEO of the French company is Alain Herrera. | Pharmaceuticals: Major | Chief Executive Officer | |
Latham BioPharm Group, Inc.
Latham BioPharm Group, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sia Partners SASU, Latham BioPharm Group, Inc. is a leading life science consulting private company that works with pharmaceutical, biotech, CROs, academia, and medical device/diagnostic companies to solve complex business, regulatory, and product development challenges. The company was founded in 1996 by Peter Latham and is based in Elkridge, MD. LBG's core services include comprehensive functional expertise in vaccines, therapeutics, cell & gene therapy, medical devices, and diagnostics. The company provides technical expertise, quality oversight, strategic analysis, and knowledge management necessary to successfully navigate the complex roadmap of life sciences product development. LBG has helped clients identify, evaluate, fund, manage, and monetize opportunities, generating over $1 billion in non-dilutive funding and over $100 million in licensing fees and investments. Latham BioPharm Group was acquired by Sia Partners SASU on October 14, 2022. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Impulse Consulting Ltd. | Director/Board Member | ||
Mitrychem SAS | Corporate Officer/Principal | ||
M2care SAS
M2care SAS Miscellaneous Commercial ServicesCommercial Services M2care SAS is a French healthcare company founded in 2017. The company is based in Lyon, France. M2care is a team of passionate entrepreneurs who invest in human and financial value to co-found, co-operate, and co-develop innovative projects in the healthcare sector until they reach the patient. | Miscellaneous Commercial Services | Director/Board Member | |
Gustave Roussy Transfert
Gustave Roussy Transfert Miscellaneous Commercial ServicesCommercial Services Gustave Roussy Transfert is a subsidiary of Gustave Roussy, the first cancer control center in France, which places innovation at the heart of care and research against cancer. The private company is based in Villejuif, France. The French company's main mission is to identify, protect, promote, and support the scientific, technological, and medical resources of Gustave Roussy. Gustave Roussy Transfert has designed a program called "Better Living Cancer" to support cancer patients during and after treatments through complementary approaches and practices to improve their quality of life. The program includes physical activity sessions, mindfulness meditation courses, and aesthetic care. | Miscellaneous Commercial Services | Director/Board Member | |
EMERCell SAS
EMERCell SAS Pharmaceuticals: MajorHealth Technology EMERCell SAS is an oncology company based in Montpellier, France. The French company is focused on developing a platform technology to produce off-the-shelf allogenic natural killer (NK) cells. The company's lead drug candidate, NK-001, is intended for the treatment of lymphoma patients who are refractory to conventional therapies. EMERCell collaborates with numerous industrial and academic partners and has received support from the Occitanie region (ADI) and Bpifrance. The company was founded in 2013 by Patrick Henno and Martin Villalba and is a member of Eurobiomed. | Pharmaceuticals: Major | Director/Board Member | |
CARSGEN THERAPEUTICS HOLDINGS LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Onward Therapeutics SA
Onward Therapeutics SA BiotechnologyHealth Technology Onward Therapeutics SA is a Swiss development stage oncology company that focuses on identifying innovative technologies and developing breakthrough medicines for cancer treatment. The private company was founded by Alain Herrera and is based in Biopole, Switzerland, a life sciences campus in Epalinges, near Lausanne. The company acquires licenses for potential development candidates and invests in partners with transformative technology platforms. Onward recently licensed a preclinical stage bispecific antibody targeting two immune checkpoints and invested in the series A financing round in Biomunex Pharmaceuticals SAS. Onward also has an affiliate in Montpellier, France, and an office in Boston. | Biotechnology | Founder | |
Big Booster Club | Chief Executive Officer |
Statistik
International
Frankreich | 24 |
Vereinigte Staaten | 10 |
Vereinigtes Königreich | 5 |
Italien | 3 |
Spanien | 3 |
Sektoral
Health Technology | 18 |
Consumer Services | 12 |
Commercial Services | 8 |
Finance | 4 |
Distribution Services | 2 |
Operativ
Corporate Officer/Principal | 40 |
Director/Board Member | 36 |
Chief Executive Officer | 12 |
Chief Tech/Sci/R&D Officer | 10 |
Independent Dir/Board Member | 9 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Anne-Marie Graffin | 22 |
Gary Phillips | 20 |
Alain Herrera | 17 |
Enno Spillner | 13 |
Laurent Lévy | 9 |
Anne-Juliette Hermant | 9 |
Raffaele Baffa | 9 |
Louis Kayitalire | 8 |
Philippe Mauberna | 6 |
Patrick Tricoli | 2 |
Brandon Owens | 2 |
Margaret Galluzzi | 1 |
Leonard A. Farber | 1 |
Mariam Hamze | 1 |
Craig West | 1 |
- Börse
- Insiders
- Bart van Rhijn
- Unternehmensverbindungen